FDA's Caronia Strategy Hampers Its Tactics In Amarin Court Case

Judge rejects FDA's narrow interpretation of earlier case and extends First Amendment protection to proactive statements by sales reps.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from United States

More from North America